SCHEMBL21963786

SCHEMBL21963786

CCOc1ccc(N2C[C@H]3CN(C(=O)O)C[C@@H]2C(C)(C)C3)cc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.40
TSHR P16473 2/20 0.40
USP2 O75604 1/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
ALDH1A1 P00352 4/20 0.38
GAA P10253 2/20 0.38
NPY2R P49146 1/20 0.38
CNR2 P34972 1/20 0.38
MAPT P10636 1/20 0.37
PKM P14618 1/20 0.37
MAPK1 P28482 1/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 1/20 0.36
HSD17B10 Q99714 1/20 0.36
FFAR1 O14842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20898289 0.88 ACACB (0.36) KMT2AMEN1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL22555742 0.87 KMT2A (0.36) TP53TSHRUSP2KMT2AMEN1
SCHEMBL22567674 0.84 ACACB (0.36) TP53TSHRUSP2KMT2AMEN1
SCHEMBL22555824 0.84 ALDH1A1 (0.37) TP53TSHRUSP2KMT2AMEN1
SCHEMBL20907250 0.84 ACACB (0.36) TP53TSHRUSP2KMT2AMEN1
SCHEMBL22555743 0.84 KMT2A (0.39) TP53TSHRUSP2KMT2AMEN1
SCHEMBL22567379 0.84 ACACB (0.36) TP53TSHRUSP2KMT2AMEN1
SCHEMBL20898268 0.83 TDP1 (0.31) GAAMAPTKDM4ELMNA
SCHEMBL22555795 0.83 ALDH1A1 (0.35) TSHRUSP2KMT2AMEN1ALDH1A1
SCHEMBL20898267 0.82 POLB (0.33) MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3880664-A1 LOX INHIBITORS The Institute of Cancer Research: Royal Cancer Hospital (GB) 2021-09-22 EP disclosed
WO-2020099886-A1 LOX INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2020-05-22 WO disclosed